 |
 |
Editorial
- Page Path
-
- HOME
- ARTICLE CATEGORY
- Editorial
- Corticosteroid, a double-edged sword in inflammatory bowel disease management: possibility of reducing corticosteroid use through physician education
- Seulji Kim, Seong-Joon Koh
- Intest Res. 2022;20(4):389-391. Published online October 28, 2022
- Full text PubReader ePub Crossref - TDM PDF
- Prevention of postoperative recurrence in Crohn’s disease: the never-ending story
- Jung-Bin Park, Sang Hyoung Park
- Intest Res. 2022;20(3):279-280. Published online July 26, 2022
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?
- Yong Eun Park
- Intest Res. 2022;20(2):157-158. Published online April 29, 2022
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?
- Jihye Park
- Intest Res. 2022;20(1):1-2. Published online January 26, 2022
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Does cytomegalovirus load predict the outcome of acute severe ulcerative colitis?
- You Sun Kim
- Intest Res. 2021;19(4):357-359. Published online October 26, 2021
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Inflammatory bowel diseases
- The first step to unveil the epidemiology of inflammatory bowel disease in Central Asia
- Seung Wook Hong, Byong Duk Ye
- Intest Res. 2020;18(4):345-346. Published online October 26, 2020
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Education levels and survival in colorectal cancer: is there really an obvious association?
- Bruna Valiati, Rodrigo Oliva Perez, Paulo Gustavo Kotze
- Intest Res. 2020;18(3):247-248. Published online July 20, 2020
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Inflammatory bowel diseases
- Tumor necrosis factor-α inhibitor use in patients with malignancy: is it safe?
- Gyu Man Oh, Won Moon
- Intest Res. 2020;18(3):245-246. Published online July 20, 2020
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Complementary and alternative medicine in patients with inflammatory bowel disease: hype or evidence?
- Jae Myung Cha
- Intest Res. 2020;18(2):141-143. Published online April 20, 2020
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Enteral nutrition in the biologic era: learn from yesterday, live for today, hope for tomorrow
- Tadakazu Hisamatsu
- Intest Res. 2020;18(2):139-140. Published online April 20, 2020
- Full text PubReader ePub Crossref - TDM PDF
|
|
- IBD
- Tacrolimus in pediatric ulcerative colitis: does it have a role?
- Seung Kim
- Intest Res. 2019;17(4):441-442. Published online October 28, 2019
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Subcutaneous integrin inhibitors may provide more treatment options for patients with moderate-to-severe ulcerative colitis
- Hyuk Yoon
- Intest Res. 2019;17(3):283-284. Published online July 25, 2019
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Can vitamin D supplementation help control inflammation in inflammatory bowel disease beyond its classical role in bone health?
- Sung Wook Hwang
- Intest Res. 2019;17(2):157-159. Published online April 24, 2019
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Multi-session fecal microbiota transplantation using colonoscopy has favorable outcomes for the treatment of steroid-dependent ulcerative colitis
- Young-Seok Cho
- Intest Res. 2019;17(1):6-8. Published online January 25, 2019
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Home-based fecal calprotectin test is expected to play an important role in patients with inflammatory bowel diseases
- Young-Ho Kim
- Intest Res. 2018;16(4):507-508. Published online October 25, 2018
- Full text PubReader ePub Crossref - TDM PDF
|
|
- Editorial Office
-
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145 Fax: +82-2-957-6146 E-mail: thekasid@irjournal.org
Copyright © 2023 by Korean Association for the Study of Intestinal Diseases.
